Locations:
Search IconSearch
November 23, 2016/Cancer/News & Insight

The Pitfalls of Promises

How should an oncologist respond to a patient’s fear of death?

650×450-Cleveland-Clinic-Cancer

By Mikkael Sekeres, MD, MS

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Three-quarters of the way through inpatient rounds, my team and I stopped to see our patient, a woman in her 50s who had been given a diagnosis of acute lymphocytic leukemia and had been started on chemotherapy over three weeks earlier. She had been doing well and her blood counts were starting to recover, so she would soon go home.

Her eyes were anxious, though, and she wrung her hands.

I met her eyes, and smiled a bit. “You’ve done great throughout your chemotherapy course, you’re on minimal medications, and your bone marrow is recovering. We aren’t at all nervous about you,” I said. “Why are you worried?”

She exhaled, though I couldn’t tell if she did so because she was relieved to hear about her good health, or frustrated that she had to repeat herself. “I’ve seen family members die in the hospital and I don’t want that to happen to me,” she said. “Promise me I won’t die here.”

Read the full New York Times column by Dr. Sekeres, Director of Cleveland Clinic Cancer Center’s Leukemia Program.

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024/Cancer/Blood Cancers
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024/Cancer
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

Ad